comparemela.com
  1. Home
  2. Live Updates
  3. Measep Ianalumab - Breaking News

Latest Breaking News On - Measep ianalumab - Page 1 : comparemela.com

Novartis Pharma AG: Novartis R&D day spotlights attractive growth profile, underpinned by strong in-market brands, 20 potential high value pipeline assets, and technology platforms

Focused medicines company delivering strong operational performanceBuilding depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint Confident to grow

United statesRichard jarvisIsabella zinckThomas hungerbuehlerSamir shahParag mahantiJulie masowSloan simpsonMeasep ianalumabAlina levchukExchange commissionAmerican society of hematologyTargeted protein degradationCell therapyGene therapyRadioligand therapy

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.